ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
作者信息
van der Heijde D, Braun J, Landewé R, Davis J, Sieper J, van der Linden S, Dougados M
机构信息
Divison of Rheumatology, University Hospital Maastricht, PO Box 5800, 6202 AZ Maastricht, the Netherlands.
出版信息
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii108-9. doi: 10.1136/ard.2004.030858.
Abstract
摘要
相似文献
1
ASessment in Ankylosing Spondylitis (ASAS) international working group: a model for psoriatic arthritis and psoriasis?
Ann Rheum Dis. 2005 Mar;64 Suppl 2(Suppl 2):ii108-9. doi: 10.1136/ard.2004.030858.
2
Comment on: Is axial psoriatic arthritis distinct from ankylosing spondylitis with and without concomitant psoriasis?
Rheumatology (Oxford). 2021 Jan 5;60(1):e24-e25. doi: 10.1093/rheumatology/kez670.
3
[Physiopathological interpretation and progress in diagnosis and treatment. 4. Psoriatic arthritis and ankylosing spondylitis].
Nihon Naika Gakkai Zasshi. 2000 Oct 10;89(10):2099-104.
4
[Early diagnostics and therapy of spondyloarthritis including psoriatric arthropathy].
Z Rheumatol. 2012 Jan;71(1):17-8. doi: 10.1007/s00393-011-0893-4.
5
Characterising the axial phenotype of psoriatic arthritis: a study comparing axial psoriatic arthritis and ankylosing spondylitis with psoriasis from the REGISPONSER registry.
RMD Open. 2022 Dec;8(2). doi: 10.1136/rmdopen-2022-002513.
6
Therapies for axial disease in psoriatic arthritis. A systematic review.
J Rheumatol. 2006 Jul;33(7):1431-4. Epub 2006 May 15.
7
Clinical Characteristics of Patients With Psoriatic Spondylitis Versus Those With Ankylosing Spondylitis: Features at Baseline Before Biologic Therapy.
J Korean Med Sci. 2022 Aug 22;37(33):e253. doi: 10.3346/jkms.2022.37.e253.
8
[Acquired hyperostosis syndrome alias arthroosteitis pustulosa (also an extension and comment on T. Nagel et. al.: Arthroosteitis pustulosa, pustulo-psoriatic hyperostotic spondylarthritis, SAPHO syndrome: clinical experiences and review of the literature].
Z Rheumatol. 1994 May-Jun;53(3):164-8; author reply 169-70.
9
Psoriatic spondylitis or ankylosing spondylitis with psoriasis: same or different?
Curr Opin Rheumatol. 2019 Jul;31(4):329-334. doi: 10.1097/BOR.0000000000000609.
10
Clinical aspects of the spondyloarthropathies.
Am J Med Sci. 1998 Oct;316(4):234-8. doi: 10.1097/00000441-199810000-00003.
引用本文的文献
1
[Outcome parameters for use in psoriatic arthritis].
Z Rheumatol. 2006 Mar;65(2):110, 112-8, 120-3. doi: 10.1007/s00393-006-0046-3.
本文引用的文献
1
International ASAS consensus statement for the use of anti-tumour necrosis factor agents in patients with ankylosing spondylitis.
Ann Rheum Dis. 2003 Sep;62(9):817-24. doi: 10.1136/ard.62.9.817.
2
Initiation of biological agents in patients with ankylosing spondylitis: results of a Delphi study by the ASAS Group.
Ann Rheum Dis. 2003 Sep;62(9):812-6. doi: 10.1136/ard.62.9.812.
3
Ankylosing spondylitis assessment group preliminary definition of short-term improvement in ankylosing spondylitis.
Arthritis Rheum. 2001 Aug;44(8):1876-86. doi: 10.1002/1529-0131(200108)44:8<1876::AID-ART326>3.0.CO;2-F.
4
Ankylosing spondylitis: plenary discussion and results of voting on selection of domains and some specific instruments.
J Rheumatol. 1999 Apr;26(4):1003-5.
5
6
Preliminary core sets for endpoints in ankylosing spondylitis. Assessments in Ankylosing Spondylitis Working Group.
J Rheumatol. 1997 Nov;24(11):2225-9.
Zotero 插件